Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):5354–5357. doi: 10.1128/iai.65.12.5354-5357.1997

A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity.

T C Caesar-TonThat 1, J E Cutler 1
PMCID: PMC175773  PMID: 9393840

Abstract

A monoclonal antibody (MAb) to Candida albicans (MAb B6.1) that protects against candidiasis and the nonprotective MAb B6 were compared for ability to support neutrophil (polymorphonuclear leukocyte [PMN]) candidacidal activity. Both MAbs are immunoglobulin M, and each recognizes distinct C. albicans mannan cell wall determinants. PMN candidacidal activity was assessed by transmission electron microscopy and by an in vitro killing assay. The results indicated that MAb B6.1, but not MAb B6, enhances ingestion and killing of yeast cells by PMN in the presence of serum complement.

Full Text

The Full Text of this article is available as a PDF (769.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashman R. B., Papadimitriou J. M. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev. 1995 Dec;59(4):646–672. doi: 10.1128/mr.59.4.646-672.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cutler J. E., Thompson B. D. A simple and inexpensive method for assessing in vitro candidacidal activity of leukocytes. J Immunol Methods. 1984 Jan 20;66(1):27–33. doi: 10.1016/0022-1759(84)90244-8. [DOI] [PubMed] [Google Scholar]
  3. Filler S. G., Swerdloff J. N., Hobbs C., Luckett P. M. Penetration and damage of endothelial cells by Candida albicans. Infect Immun. 1995 Mar;63(3):976–983. doi: 10.1128/iai.63.3.976-983.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gelfand J. A., Hurley D. L., Fauci A. S., Frank M. M. Role of complement in host defense against experimental disseminated candidiasis. J Infect Dis. 1978 Jul;138(1):9–16. doi: 10.1093/infdis/138.1.9. [DOI] [PubMed] [Google Scholar]
  5. Han Y., Cutler J. E. Antibody response that protects against disseminated candidiasis. Infect Immun. 1995 Jul;63(7):2714–2719. doi: 10.1128/iai.63.7.2714-2719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Han Y., Cutler J. E. Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J Infect Dis. 1997 May;175(5):1169–1175. doi: 10.1086/516455. [DOI] [PubMed] [Google Scholar]
  7. Han Y., Kanbe T., Cherniak R., Cutler J. E. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun. 1997 Oct;65(10):4100–4107. doi: 10.1128/iai.65.10.4100-4107.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hostetter M. K. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin Microbiol Rev. 1994 Jan;7(1):29–42. doi: 10.1128/cmr.7.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kanbe T., Han Y., Redgrave B., Riesselman M. H., Cutler J. E. Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect Immun. 1993 Jun;61(6):2578–2584. doi: 10.1128/iai.61.6.2578-2584.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klotz S. A. Plasma and extracellular matrix proteins mediate in the fate of Candida albicans in the human host. Med Hypotheses. 1994 May;42(5):328–334. doi: 10.1016/0306-9877(94)90008-6. [DOI] [PubMed] [Google Scholar]
  11. Kozel T. R., Weinhold L. C., Lupan D. M. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect Immun. 1996 Aug;64(8):3360–3368. doi: 10.1128/iai.64.8.3360-3368.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morelli R., Rosenberg L. T. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J Immunol. 1971 Aug;107(2):476–480. [PubMed] [Google Scholar]
  13. Morrison R. P., Cutler J. E. In vitro studies of the interaction of murine phagocytic cells with Candida albicans. J Reticuloendothel Soc. 1981 Jan;29(1):23–34. [PubMed] [Google Scholar]
  14. Ray T. L., Wuepper K. D. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J Invest Dermatol. 1976 Dec;67(6):700–703. doi: 10.1111/1523-1747.ep12598581. [DOI] [PubMed] [Google Scholar]
  15. Shibata N., Ikuta K., Imai T., Satoh Y., Satoh R., Suzuki A., Kojima C., Kobayashi H., Hisamichi K., Suzuki S. Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J Biol Chem. 1995 Jan 20;270(3):1113–1122. doi: 10.1074/jbc.270.3.1113. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES